Epilepsy Drug Weight Loss: How It Works
- A study published in the journal Obesity explores the mechanisms behind the weight-loss effects of topiramate, a drug originally designed to treat epilepsy, and its implications for personalized...
- Published October 3, 2024, and reviewed on October 3, 2025, at 18:31:49.
- Topiramate, often combined with phentermine in the drug QSYMIA, is known to promote weight loss, but the precise way it achieves this has remained unclear.
new Research sheds Light on How Weight-Loss Drugs work
Table of Contents
A study published in the journal Obesity explores the mechanisms behind the weight-loss effects of topiramate, a drug originally designed to treat epilepsy, and its implications for personalized obesity treatment.
Published October 3, 2024, and reviewed on October 3, 2025, at 18:31:49.
The Puzzle of Topiramate’s Weight-Loss Effect
Topiramate, often combined with phentermine in the drug QSYMIA, is known to promote weight loss, but the precise way it achieves this has remained unclear. Unlike liraglutide (Saxenda), topiramate does not directly impact neurons regulating satiety-the feeling of fullness. This new research aims to unravel the alternative pathways through which it exerts its effects.
the study, signed by moein Minbashi Moeini, Olivier Lavoie, Alexandre caron from Laval University, and Kevin Williams from the University of Texas Southwestern Medical Center, seeks to better understand appetite suppressant molecules to personalize obesity treatments and maximize their effectiveness.The research was published in the journal Obesity.
QSYMIA and Weight Loss Variability
Individuals taking QSYMIA typically experience an average weight loss of 10%. However, Professor Natalie Jane Michael of Laval University emphasizes that results are highly variable. “The results are very variable,” she stated. “In some people, weight loss is negligible, while in others it can reach 20% of body weight.”
This variability isn’t unique to QSYMIA; it’s also observed with medications like Ozempic, where some individuals even report weight gain while on the drug. Understanding the underlying mechanisms of these drugs could lead to more tailored treatment plans.
The Need for Personalized Obesity Treatment
The differing responses to weight-loss medications highlight the importance of personalized medicine. Genetic predispositions and individual responses to food intake play a notable role in determining treatment success. A deeper understanding of how these drugs interact with individual biology could optimize outcomes for people living with obesity.